Gregory A. Lizee, Ph.D.
Affiliations: | 2000 | University of British Columbia, Vancouver, Vancouver, BC, Canada |
Area:
Immunology, Molecular BiologyGoogle:
"Gregory Lizee"Mean distance: 26716.5
Parents
Sign in to add mentorWilfred A. Jefferies | grad student | 2000 | UBC | |
(MHC class I cytoplasmic domain: Defining a role for conserved amino acid residues in class I expression, trafficking, and antigen presentation.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Chaudhri A, Bu X, Wang Y, et al. (2023) The CX3CL1-CX3CR1 chemokine axis can contribute to tumor immune evasion and blockade with a novel CX3CR1 monoclonal antibody enhances response to anti-PD-1 immunotherapy. Frontiers in Immunology. 14: 1237715 |
Hall-Swan S, Slone J, Rigo MM, et al. (2023) PepSim: T-cell cross-reactivity prediction via comparison of peptide sequence and peptide-HLA structure. Frontiers in Immunology. 14: 1108303 |
Liang S, Jiang X, Chiu Y, et al. (2023) An interpretable ML model to characterize patient-specific HLA-I antigen presentation. Biorxiv : the Preprint Server For Biology |
Hailemichael Y, Johnson DH, Abdel-Wahab N, et al. (2022) Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity. Cancer Cell. 40: 509-523.e6 |
Sun Y, Li F, Sonnemann H, et al. (2021) Evolution of CD8 T Cell Receptor (TCR) Engineered Therapies for the Treatment of Cancer. Cells. 10 |
Li F, Deng L, Jackson KR, et al. (2021) Neoantigen vaccination induces clinical and immunologic responses in non-small cell lung cancer patients harboring EGFR mutations. Journal For Immunotherapy of Cancer. 9 |
Saberian C, Amaria RN, Najjar AM, et al. (2021) Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma. Journal For Immunotherapy of Cancer. 9 |
Yoshihama S, Cho SX, Yeung J, et al. (2021) NLRC5/CITA expression correlates with efficient response to checkpoint blockade immunotherapy. Scientific Reports. 11: 3258 |
Bradley SD, Talukder AH, Lai I, et al. (2020) Vestigial-like 1 is a shared targetable cancer-placenta antigen expressed by pancreatic and basal-like breast cancers. Nature Communications. 11: 5332 |
Phillips S, Lizee G, Brown C, et al. (2020) A phase Ib study of endogenous SLC45A2-specific cytotoxic T cells for the treatment of patients with metastatic uveal melanoma. Journal of Clinical Oncology. 38 |